Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Highly Accessed Case report

Babesia microti: an unusual travel-related disease

Elodie Poisnel1, Mikael Ebbo1, Yael Berda-Haddad2, Benoit Faucher3, Emmanuelle Bernit1, Bernard Carcy4, Renaud Piarroux3, Jean-Robert Harlé1 and Nicolas Schleinitz1*

Author affiliations

1 Service de médecine interne, AP-HM, Aix-Marseille Université, Marseille cedex 5, 13385, France

2 Laboratoire d’hématologie, AP-HM, Aix-Marseille Université, Marseille cedex 5, 13385, France

3 Laboratoire de Parasitologie, AP-HM, Aix-Marseille Université, Marseille cedex 5, 13385, France

4 Laboratoire de Biologie Cellulaire et Moléculaire Université Montpellier I Faculté de Pharmacie, 15 Avenue Charles Flahault, Montpellier Cedex 5, 134093, France

For all author emails, please log on.

Citation and License

BMC Infectious Diseases 2013, 13:99  doi:10.1186/1471-2334-13-99


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/13/99


Received:22 June 2012
Accepted:18 February 2013
Published:22 February 2013

© 2013 Poisnel et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Human babesiosis is a rare tick-borne infectious disease. The clinical presentation ranges from an asymptomatic form to a life threatening infection with severe hemolysis. Human babesiosis due to Babesia microti is the most common and is endemic in North America.

Case presentation

We report a European patient with severe pancytopenia and reactive hemophagocytosis related to a Babesia microti infection. Babesia infection was acquired during a travel in the USA.

Conclusion

Babesiosis should be considered in patients who traveled in endemic areas, especially North America for the most common agent Babesia microti.

Keywords:
Babesiosis; Babesia microti; Hemophagocytosis; Travel-related diseases

Background

Human babesiosis is a tick-borne infectious disease caused by intraerythrocytic protozoan species of the genus Babesia transmitted by Ixodes. Babesia microti is the most common cause of human babesiosis endemic in USA on the northeastern seabord and the upper midwest. The first confirmed case was a normosplenic individual on Nantucket Island published in 1970 [1]. After additional cases the disease became known as Nantucket fever. The incubation period may last from 1 to 9 weeks and clinical features are similar to those of malaria. The severity is variable depending on the immune status of the host, ranging from an asymptomatic infection to a severe life threatening disease [2]. Severe disease generally occurs in patients over the age of 50 years or with splenectomy, malignancy, HIV, or immunosuppressive medication. B. microti infections can also rarely be acquired by transfusion of blood products from asymptomatic donors [3]. In Europe few isolated cases have been reported related to other Babesia species: B. divergens and B. venatorum. Most of European cases are observed in splenectomized patients [2].

Case report

A 82-year-old man living on the French Riviera presented at the emergency department for fever and chills lasting for 5 days. He complained of severe asthenia. He came back two weeks ago from a travel in New York city, USA with a two days stay on the Long Island countryside. He did not note any insect bite during his travel. Jaundice was noticed on examination as well as slightly enlarged spleen and liver. Blood test showed an abnormal blood cell count with neutropenia (0·5 G/L), lymphopenia (0·3 G/L), thrombocytopenia (30×109/L) and anemia (haemoglobin of 91 g/L) with a low reticulocyte count (45 G/L). Blood test also showed increased C reactive protein (154 mg/L), raised ferritin (5953 ng/ml) and liver enzymes were elevated (ALT 56 UI/L (N<40), AST 68 UI/L (N<53), Alkaline phosphatase 213 UI/L (N<129), total bilirubin 48·9 μmol/L). Haptoglobin was undetectable, LDH levels increased 620 UI/L (N<225) and coagulation tests were in normal range. Routine blood cultures were negative. Bone marrow aspiration was performed because of the severe cytopenias associated with a low reticulocyte count and showed typical hemophagocytosis (Figure 1A). Microscopic examination of the blood smear and the bone marrow stained with Giemsa showed intra-eryhtrocytic parasites (Figure 1B). The parasitemia was evaluated about 3% of red blood cells. Rapid testing for Plasmodium falciparum by PCR revealed negative. Intravenous treatment for babesiosis with clindamycin and quinine was started. Patient’s clinical status improved with the resolution of the fever after 3 days of treatment. Blood analysis improved after the 10 days treatment course (haemoglobin 104 g/L, platelets 220×109/L, neutrophils 3 G/L, C reactive protein 16 mg/L). PCR testing on blood for babesia was positive (Figure 2A). Babesia microti was confirmed by PCR with specific primers (LDH gene amplification) as shown on Figure 2B. Serology for Borrelia burgdorferi, the agent of Lyme disease, was negative.

thumbnailFigure 1. A; Bone marrow smear stained with Giemsa (magnification x 100). The picture shows a macrophage with phagocytosis of a neutrophil. On the right side an intra-erythrocytic ring of Babesia microti can be observed in a red blood cell (arrow). B; Blood smear stained with Giemsa (magnification x 100) showing intra-erythrocytic forms of Babesia microti.

thumbnailFigure 2. Polymerase chain reaction results for Babesia microti in patients blood (C=H20, negative control; B.d= Babesia divergens strain R87, positive control; B.m= Babesia microti strain T, positive control; P=Patient). PCR was done with specific primers for Babesia [4] in 2A and specific amplification of the LDH gene of Babesia microti in 2B.

Discussion

The clinical symptoms and the biological abnormalities observed during babesiosis are very similar to Plasmodium infection. Thus malaria is often evoked even in travelers who have never visited a malarious area because of the rare “airport malaria” [5]. This case underline that the diagnosis of babesiosis should be considered in patients who traveled in endemic areas, especially North America, for the most common agent Babesia microti. Babesia microti infection cannot be ruled out in patients with intact spleen in contrary to the European Babesia species (Babesia divergens and Babesia venatorum)[2]. Moreover in some rare cases spontaneous splenic rupture secondary to babesia microti infection have been reported [6]. Babesiosis has been reported to be associated to reactive hemophagocytosis in few cases [7,8] however regenerative hemolytic anemia is the most usual presentation [2]. In the present case the unusual severe neutropenia and non-regenerative anemia led to the bone marrow aspiration analysis. Typical hemophagocytosis was seen however without evidence of phagocytosis of babesia infected red blood cells.

Diagnosis of babesia is usually strongly evoked by the blood smear analysis and can be confirmed by specific PCR, allowing to identify Babesia species and to exclude plasmodium infection. Despite some similarities with plasmodium, babesiosis does not respond to chloroquine. The use of clindamycin with quinine have been shown to be effective as the combination of atovaquone and azithromycin [2,9]. Because Borrelia burgdorferi, the agent of Lyme disease, is transmitted by the same tick and is endemic in North America it should systematically be screened by serology in these patients.

Conclusion

The diagnosis of babesiosis should be considered in patients who traveled in endemic areas especially North America for the most common agent Babesia microti. Blood analyses usually show regenerative hemolytic anemia, thrombocytopenia, and elevated liver enzymes. In case of pancytopenia associated with non-regenerative anemia reactive hemophagocytosis should be evoked. Diagnosis of babesiosis can be made on blood smear analysis but needs usually more specific tests, as PCR, to be confirmed.

Consent

The patient has given his consent for the publication of this case report.

Competing interests

The authors declare that they have no competing interests.

Authors’ contribution

All authors have participated substantially in order to be considered as authors in this case report. All authors read and approved the final manuscript.

References

  1. Western KA, Benson GD, Gleason NN, Healy GR, Schultz MG: Babesiosis in a Massachusetts resident.

    N Engl J Med 1970, 283:854-856. PubMed Abstract | Publisher Full Text OpenURL

  2. Vannier E, Krause PJ: Human babesiosis.

    N Engl J Med 2012, 366:2397-2407. PubMed Abstract | Publisher Full Text OpenURL

  3. Herwaldt BL, Linden JV, Young C, Olkowska D, Wilson M: Transfusion-Associated Babesiosis in the United States: A Description of Cases.

    Ann Intern Med 2011, 155:509-519. PubMed Abstract | Publisher Full Text OpenURL

  4. Olmeda AS, Armstrong PM, Rosenthal BM, Valladares B, del Castillo A, de Armas F, Miguelez M, González A, Rodríguez Rodríguez JA, Spielman A, Telford SR 3rd: A subtropical case of human babesiosis.

    Acta Trop 1997, 67:229-234. PubMed Abstract | Publisher Full Text OpenURL

  5. Isaäcson M: Airport malaria: a review.

    Bull World Health Organ 1989, 67:737-743. PubMed Abstract | PubMed Central Full Text OpenURL

  6. Kuwayama DP, Briones RJ: Spontaneous splenic rupture caused by Babesia microti infection.

    Clin Infect Dis 2008, 46(9):e92-e95. PubMed Abstract | Publisher Full Text OpenURL

  7. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C: Infections associated with haemophagocytic syndrome.

    Lancet Infect Dis 2007, 7:814-822. PubMed Abstract | Publisher Full Text OpenURL

  8. Auerbach M, Haubenstock A, Soloman G: Systemic babesiosis. Another cause of the hemophagocytic syndrome.

    Am J Med 1986, 80:301-303. PubMed Abstract | Publisher Full Text OpenURL

  9. Weiss LM: Babesiosis in humans: a treatment review.

    Expert Opin Pharmacother 2002, 3(8):1109-1115.

    Changer

    PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/13/99/prepub